Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 24 Jan 2023 for Pear Therapeutics, Inc., €36k.
Filing timeline
BuySaleCorey McCann
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Corey McCann: trading record in brief
Corey McCann (chief executive) discloses dealings in Pear Therapeutics, Inc. to SEC (Form 4). We count 5 filings; the first trade dates from 3 December 2021 and the latest from 20 January 2023.
No open-market purchase appears, only 1 sale worth €36k. The rest of the record consists of 3 share grants and 1 option exercise. 2023 to date brings no purchases and 1 sale.
The latest filing, published on 24 January 2023, reports an open-market sale of €36k in Pear Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Corey McCann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
34,731 shares@ US$1.13100.0% of flowClass A Common StockSEC:0001062993-23-001323:0
88,000 shares0Common StockSEC:0001062993-23-001039:0
8,157,656 sharesClass A Common StockSEC:0001062993-21-012388:0
3 of 3 declarations
